MBX Capital logo

MBX Capital

North America, New York, United States, New York

Description

MBX Capital is a venture capital partnership investing in early-stage healthcare, life sciences, and environmental health companies

Investor Profile

MBX Capital has made 45 investments, with 3 in the past 12 months and 7% as lead.

Stage Focus

  • Series A (49%)
  • Seed (36%)
  • Series B (9%)
  • Series Unknown (7%)

Country Focus

  • United States (93%)
  • Canada (4%)
  • India (2%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Medical Device
  • Information Technology
  • Dental
  • Pharmaceutical
  • Life Science
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does MBX Capital frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 3
Shangbay Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Rhia Ventures
North America, New York, United States, Bellerose
Co-Investments: 2
FundRx
North America, New York, United States, New York
Co-Investments: 5
PsyMed Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Graphene Ventures
North America, California, United States, Palo Alto
Co-Investments: 2
Metaplanet
Europe, Harjumaa, Estonia, Tallinn
Co-Investments: 2
AXA Venture Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Village Global
North America, California, United States, Covina
Co-Investments: 4
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 3

Which angels does MBX Capital often collaborate with?

JW
North America, Virginia, United States, Charlottesville
Shared Deals: 1
SP
North America, California, United States, San Francisco
Shared Deals: 1
VP
North America, Massachusetts, United States, Boston
Shared Deals: 1
A(
North America, Massachusetts, United States, Boston
Shared Deals: 1
RS
North America, Georgia, United States, Atlanta
Shared Deals: 1
ME
North America, California, United States, Beverly Hills
Shared Deals: 1
AW
North America, California, United States, San Francisco
Shared Deals: 1
AI
Europe, Cyprus
Shared Deals: 1
SB
North America, New York, United States, New York
Shared Deals: 1
WS
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 1

What are some of recent deals done by MBX Capital?

Vivodyne

San Francisco, California, United States

Vivodyne accelerates drug discovery using lab-grown human tissues, robotics, and AI to generate accurate preclinical test data.

BiotechnologyLifestyleMedical
Series AMay 29, 2025
Amount Raised: $40,000,000
CND Life Sciences

Scottsdale, Arizona, United States

CND Life Sciences is a life sciences company that develops an evidence-based tool for detecting neurodegenerative diseases.

BiotechnologyHealth DiagnosticsLife ScienceMedical
Series AMay 1, 2025
Amount Raised: $13,500,000
Keebler Health

Durham, North Carolina, United States

Keebler Health is a developer of an AI-based risk adjustment tool for healthcare providers.

Artificial Intelligence (AI)BillingInformation Technology
SeedFeb 18, 2025
Amount Raised: $6,000,000
Tidal Vision

Bellingham, Washington, United States

Tidal Vision manufactures chitosan-based biomolecular solutions for some of humanity's chemistry and pollution.

AgricultureBiotechnologyManufacturing
Series BFeb 5, 2025
Amount Raised: $140,000,000
Waypoint Bio

New York, New York, United States

Optimizing cell therapy with spatial biology

Biotechnology
SeedJun 28, 2024
Amount Raised: $14,500,000
Vivodyne

Philadelphia, Pennsylvania, United States

Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.

BiotechnologyLifestyleMedical
SeedNov 22, 2023
Amount Raised: $38,000,000
Forum

New York, New York, United States

Forum helps people navigate life’s biggest challenges through the power of peer support groups.

Health CareMental Health
SeedNov 8, 2023
Amount Raised: $5,300,000
Macro Trials

Los Angeles, California, United States

Clinical trials. Reimagined.

BiopharmaClinical TrialsHealth CareLife Science
SeedJun 21, 2023
Amount Raised: $6,000,000
Thesis

New York, New York, United States

Thesis offers personalized brain supplements focused on mental performance.

Health CarePharmaceuticalWellness
SeedMay 2, 2023
Amount Raised: $5,100,000
Contraline

Charlottesville, Virginia, United States

Contraline is developing the first long-lasting, non-hormonal, reversible contraceptive for men

BiotechnologyHealth CareMedical Device
Series ANov 10, 2022
Amount Raised: $7,200,000